VC-backed Pliant Therapeutics goes public
South San Francisco-based Pliant Therapeutics Inc, a developer of therapies that treat fibrosis, has raised $144 million for its IPO after it priced its 9 million shares at $16 per share.
3 June 2020•3 mins read
